Concepedia

Author

Esteban Abella

Wayne State University

Also Known As

E ABELLA, E Abella, E M Abella, E. Abella, Esteban Abella, Esteban M Abella, Esteban M. Abella

86

Publications

1.8K

Citations

21

H-Index

46

Concepts

All Affiliations

Wayne State UniversityThe Barbara Ann Karmanos Cancer InstituteChildren's Hospital of MichiganDetroit Medical CenterHarper University Hospital
EA

About

Esteban Abella is an author at Wayne State University specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

12

387

2

Health Sciences

6

6

182

3

Blood Transplantation

3

3

59

4

Cell Biology

2

2

35

5

Cellular Physiology

1

1

10

Esteban Abella

×

25

Publications

1.2K

Citations

18

H-Index

YearCitations

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 [see comments]

Yaddanapudi Ravindranath, Esteban Abella, J. Krischer,

Blood

1992

257

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

V. Ratanatharathorn, Joseph P. Uberti, Chatchada Karanes,

Blood

1994

226

Assessment of Optimal Size and Composition of the U.S. National Registry of Hematopoietic Stem Cell Donors

Craig Kollman, Esteban Abella, Robert L. Baitty,

Transplantation

2004

112

A case report of a patient with microcephaly, facial dysmorphism, mitomycin-c-sensitive lymphocytes, and susceptibility to lymphoma

Sameer Bakhshi, Hans Joenje, Detlev Schindler,

Cancer Genetics and Cytogenetics

2006

73

FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.

Arlene O. Siefker‐Radtke, Graeme Currie, Esteban Abella,

Journal of Clinical Oncology

2019

64

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

R. Lamba, Esteban Abella, Debra Kukuruga,

Leukemia

2004

57

Prevention of Hemorrhagic Cystitis Following Allogeneic Bone Marrow Transplant Preparative Regimens With Cyclophosphamide and Busulfan: Role of Continuous Bladder Irrigation

Levent N. Türkeri, Lawrence G. Lum, Joseph P. Uberti,

The Journal of Urology

1995

45

Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease

Edward Peres, Polly E. Kintzel, Roger Dansey,

Blood Coagulation & Fibrinolysis

2008

38

Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature

R. Ibrahim, E. Peres, Roger Dansey,

Bone Marrow Transplantation

2005

35

Phialophora verrucosa infection in a BMT patient

TS Lundstrom, MR Fairfax, J. Vázquez,

Bone Marrow Transplantation

1997

32

Page 1